Baird Financial Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-21,618
| Closed | -$512K | – | 1577 |
|
|
2019
Q3 | $512K | Buy |
21,618
+4,163
| +24% | +$98.6K | ﹤0.01% | 1166 |
|
|
2019
Q2 | $525K | Buy |
17,455
+523
| +3% | +$15.7K | ﹤0.01% | 1179 |
|
|
2019
Q1 | $379K | Buy |
16,932
+700
| +4% | +$15.7K | ﹤0.01% | 1085 |
|
|
2018
Q4 | $295K | Buy |
+16,232
| New | +$295K | ﹤0.01% | 1127 |
|